| Cellular backpacks for macrophage immunotherapy CW Shields IV, MA Evans, LLW Wang, N Baugh, S Iyer, D Wu, Z Zhao, ... Science Advances 6 (18), eaaz6579, 2020 | 256 | 2020 |
| Nanocarrier‐mediated cytosolic delivery of biopharmaceuticals W He, X Xing, X Wang, D Wu, W Wu, J Guo, S Mitragotri Advanced functional materials 30 (37), 1910566, 2020 | 115 | 2020 |
| Effect of nanoparticle composition, size, shape, and stiffness on penetration across the blood–brain barrier TD Brown, N Habibi, D Wu, J Lahann, S Mitragotri ACS Biomaterials Science & Engineering 6 (9), 4916-4928, 2020 | 101 | 2020 |
| Engineering of living cells with polyphenol‐functionalized biologically active nanocomplexes Z Zhao, DC Pan, QM Qi, J Kim, N Kapate, T Sun, CW Shields IV, ... Advanced Materials 32 (49), 2003492, 2020 | 62 | 2020 |
| Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments A Pusuluri, D Wu, S Mitragotri Journal of controlled release 305, 130-154, 2019 | 46 | 2019 |
| Design principles of drug combinations for chemotherapy D Wu, A Pusuluri, D Vogus, V Krishnan, CW Shields IV, J Kim, A Razmi, ... Journal of controlled release 323, 36-46, 2020 | 37 | 2020 |
| Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin A Pusuluri, V Krishnan, D Wu, CW Shields IV, LW Wang, S Mitragotri Bioengineering & Translational Medicine 4 (2), e10129, 2019 | 28 | 2019 |
| Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer DC Pan, V Krishnan, AK Salinas, J Kim, T Sun, S Ravid, K Peng, D Wu, ... Bioengineering & Translational Medicine 6 (1), e10166, 2021 | 22 | 2021 |
| Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer D Wu, Z Zhao, J Kim, A Razmi, LLW Wang, N Kapate, Y Gao, K Peng, ... Bioengineering & translational medicine 6 (1), e10188, 2021 | 22 | 2021 |
| Enhancement of Anticancer Efficacy and Tumor Penetration of Sorafenib by Ionic Liquids Y Shi, Z Zhao, K Peng, Y Gao, D Wu, J Kim, S Mitragotri Advanced Healthcare Materials 10 (2), 2001455, 2021 | 21 | 2021 |
| Hyaluronic acid nanoparticles for immunogenic chemotherapy of leukemia and T-cell lymphoma V Krishnan, V Dharamdasani, S Bakre, V Dhole, D Wu, B Budnik, ... Pharmaceutics 14 (2), 466, 2022 | 7 | 2022 |
| Optimized 5-fluorouridine prodrug for co-loading with doxorubicin in clinically relevant liposomes D Wu, D Vogus, V Krishnan, M Broto, A Pusuluri, Z Zhao, N Kapate, ... Pharmaceutics 13 (1), 107, 2021 | 4 | 2021 |
| Methods and compositions relating to improved combination therapies S Mitragotri, WU Debra US Patent App. 17/801,872, 2023 | | 2023 |
| Investigating Design Parameters for Combination Chemotherapeutic Liposomes D Wu Harvard University, 2020 | | 2020 |
| Controlling Cellular Phenotypes Via Cytokine-Releasing Backpacks for Cancer Immunotherapy CW Shields, MA Evans, LW Wang, S Iyer, D Wu, A Pusuluri, S Mitragotri 2019 AIChE Annual Meeting, 2019 | | 2019 |
